AI Analysis
switching costsmedium conviction
BILL Holdings at $5B mcap with 14% revenue growth, positive 21% operating margins, and P/S of 2.7x is deeply discounted versus Technology sector median P/S of 6.7x — a 60% discount for a profitable, cash-generating SMB fintech. Path to 5x: $5B → $25B requires $3-4B revenue at 7-8x P/S, achievable if growth re-accelerates to 18-20% over 4 years from $1.7B TTM base. At current 14% growth that's borderline — this is a 'margin of safety' valuation play, not a pure growth bet. PE of 100.8x looks high but SBC/Rev is 14%, so GAAP earnings are depressed; FCF generation is real.
Based on Q3 2026 financials (data: 2026-11-09)
Catalysts
- • AI-driven automation of AP/AR workflows could expand TAM and re-accelerate growth within SMB segment
- • Cross-sell of spend management (Divvy) and invoice products to existing customer base driving ARPU expansion
- • Potential re-rating toward sector median P/S of 6.7x alone would nearly 2.5x the stock without any revenue growth
Risks
- • Growth deceleration is the core risk: 14% is below the 23% Technology sector median, and accel data unavailable — if growth is slowing toward 10%, thesis weakens materially
- • High PE of 100.8x on GAAP basis makes the stock vulnerable to any earnings miss
- • SMB customer base is cyclically sensitive — a U.S. recession would increase churn and slow new customer adds
- • Competitive pressure from Intuit, Brex, and neobanks embedding similar functionality natively
AI Deep Dive
10/10 today
Generate an AI-powered deep dive analysis for BILL.
BILL
BILL Holdings
$57.63
Current Price
$31.4152-Week Range$58.47
Researched today
Score History
Score Breakdown
65
Composite
Multi-Bagger
30%62
Valuation
25%62
Growth
20%72
Profitability
15%62
Health
10%70
Fundamentals
Revenue Growth (YoY)12.5%
Earnings Growth (YoY)2134.2%
Gross Margin84.1%
Operating Margin6.2%
FCF Margin5.1%
Free Cash Flow$82.9M
SBC / Revenue13.1%
Share Dilution (ann.)-0.9% (buybacks)
Valuation
P/E Ratio104.78x
P/S Ratio2.92x
PEG Ratio0.45x
EV/EBITDA27.65x
Financial Health
Debt/Equity
0.53xCurrent Ratio
1.51xFree Cash Flow
$82.9M